These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27619922)

  • 1. Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target? A Protagonist View From the SPRINT Trial (Systolic Blood Pressure Intervention Trial).
    Oparil S; Lewis CE
    Circulation; 2016 Nov; 134(18):1308-1310. PubMed ID: 27619922
    [No Abstract]   [Full Text] [Related]  

  • 2. Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target? An Antagonist View From the HOPE-3 Trial (Heart Outcomes Evaluation-3).
    Lonn EM; Yusuf S
    Circulation; 2016 Nov; 134(18):1311-1313. PubMed ID: 27619924
    [No Abstract]   [Full Text] [Related]  

  • 3. In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease?
    Tyson CC; Coffman TM
    Nephron; 2017; 135(4):287-290. PubMed ID: 28161697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Pressure Variability Predicts Adverse Events and Cardiovascular Outcomes in Chronic Kidney Disease: A Post-Hoc Analysis of the SPRINT Trial.
    Mezue K; Goyal A; Pressman GS; Horrow JC; Rangaswami J
    Am J Hypertens; 2017 Dec; 31(1):48-52. PubMed ID: 28985328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines.
    Egan BM; Li J; Wagner CS
    Hypertension; 2016 Aug; 68(2):318-23. PubMed ID: 27354422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.
    Huang C; Dhruva SS; Coppi AC; Warner F; Li SX; Lin H; Nasir K; Krumholz HM
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29133522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?
    Bhatt H; Ghazi L; Calhoun D; Oparil S
    Curr Cardiol Rep; 2016 Oct; 18(10):98. PubMed ID: 27566331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiphasic effects of blood pressure on survival in hemodialysis patients.
    Hannedouche T; Roth H; Krummel T; London GM; Jean G; Bouchet JL; Drüeke TB; Fouque D;
    Kidney Int; 2016 Sep; 90(3):674-84. PubMed ID: 27521114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Risk in Hypertension in Relation to Achieved Blood Pressure Using Automated Office Blood Pressure Measurement.
    Myers MG; Kaczorowski J; Dolovich L; Tu K; Paterson JM
    Hypertension; 2016 Oct; 68(4):866-72. PubMed ID: 27528062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Managing hypertension in patients with chronic kidney disease - implications of the SPRINT study].
    Wojtaszek E; Głogowski T
    Wiad Lek; 2016; 69(5):742-744. PubMed ID: 28033599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.
    Yano Y; Rakugi H; Bakris GL; Lloyd-Jones DM; Oparil S; Saruta T; Shimada K; Matsuoka H; Imai Y; Ogihara T
    Hypertension; 2017 Feb; 69(2):220-227. PubMed ID: 28049699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPRINT trial: It's not just the blood pressure!
    Berkelmans GF; Visseren FL; Jaspers NE; Spiering W; van der Graaf Y; Dorresteijn JA
    Eur J Prev Cardiol; 2017 Sep; 24(14):1482-1484. PubMed ID: 28749177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of change in renal function and mortality in elderly treated hypertensive patients.
    Chowdhury EK; Langham RG; Ademi Z; Owen A; Krum H; Wing LM; Nelson MR; Reid CM;
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1154-61. PubMed ID: 25901093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision Medicine for Hypertension Management in Chronic Kidney Disease: Relevance of SPRINT for Therapeutic Targets in Nondiabetic Renal Disease.
    Ruzicka M; Burns KD; Hiremath S
    Can J Cardiol; 2017 May; 33(5):611-618. PubMed ID: 28365055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical decision support to improve blood pressure control in hemodialysis patients: a nonrandomized controlled trial.
    Thompson S; Hemmelgarn B; Wiebe N; Majumdar S; Klarenbach S; Jindal K; Manns B; Mortis G; Campbell P; Tonelli M;
    J Nephrol; 2012; 25(6):944-53. PubMed ID: 23147684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease.
    Mallamaci F; Minutolo R; Leonardis D; D'Arrigo G; Tripepi G; Rapisarda F; Cicchetti T; Maimone I; Enia G; Postorino M; Santoro D; Fuiano G; De Nicola L; Conte G; Zoccali C
    Kidney Int; 2013 Aug; 84(2):381-9. PubMed ID: 23615498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study.
    Xu W; Goldberg SI; Shubina M; Turchin A
    BMJ; 2015 Feb; 350():h158. PubMed ID: 25655523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive systolic blood pressure control in older subjects: benefits and risks.
    Chrysant SG
    Postgrad Med; 2018 Mar; 130(2):159-165. PubMed ID: 29375010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal Systolic Blood Pressure Levels for Primary Prevention of Stroke in General Hypertensive Adults: Findings From the CSPPT (China Stroke Primary Prevention Trial).
    Fan F; Yuan Z; Qin X; Li J; Zhang Y; Li Y; Yu T; Ji M; Ge J; Zheng M; Yang X; Bao H; Cheng X; Gu D; Zhao D; Wang J; Sun N; Chen Y; Wang H; Wang X; Parati G; Hou F; Xu X; Wang X; Zhao G; Huo Y
    Hypertension; 2017 Apr; 69(4):697-704. PubMed ID: 28242714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.